Search research articles
Contact Us
Filters
Showing results (561-570 of 594) with videos related to
Page
of 60
Sort By:
Schizophrenia Research
|
January 16, 2026
Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia
Deanna L Kelly, Christopher M Lee, Gopal Vyas, et al.
Schizophrenia Research
|
November 28, 2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study
Alan Breier, Robert W Buchanan, Deepak D'Souza, et al.
Journal of Clinical Psychopharmacology
|
June 18, 2015
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
Deanna L Kelly, Kelli M Sullivan, Joseph P McEvoy, et al.
Schizophrenia Bulletin
|
June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine Utilization
Deanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
August 28, 2020
Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study
Johanna Seitz, Suheyla Cetin-Karayumak, Amanda Lyall, et al.
The American Journal of Psychiatry
|
August 3, 2004
Physical health monitoring of patients with schizophrenia
Stephen R Marder, Susan M Essock, Alexander L Miller, et al.
Journal of Psychiatry & Neuroscience : JPN
|
April 3, 2019
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study
Deanna L. Kelly, Haley K. Demyanovich, Katrina M. Rodriguez, et al.
Schizophrenia Research
|
March 1, 2025
Building a two-state learning healthcare system for persons with first episode psychosis
Jill A Marsteller, Richard W Goldberg, Yasmine Boumaiz, et al.
Biological Psychiatry
|
December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia
Robert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Research
|
March 3, 2015
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
L Fredrik Jarskog, Martin T Lowy, Richard A Grove, et al.
Page
of 60
Search research articles
Search
Showing results (561-570 of 594) with videos related to
Sort By:
Page
of 60
Schizophrenia Research
|
January 16, 2026
Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia
Deanna L Kelly, Christopher M Lee, Gopal Vyas, et al.
Schizophrenia Research
|
November 28, 2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study
Alan Breier, Robert W Buchanan, Deepak D'Souza, et al.
Journal of Clinical Psychopharmacology
|
June 18, 2015
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
Deanna L Kelly, Kelli M Sullivan, Joseph P McEvoy, et al.
Schizophrenia Bulletin
|
June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine Utilization
Deanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
August 28, 2020
Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study
Johanna Seitz, Suheyla Cetin-Karayumak, Amanda Lyall, et al.
The American Journal of Psychiatry
|
August 3, 2004
Physical health monitoring of patients with schizophrenia
Stephen R Marder, Susan M Essock, Alexander L Miller, et al.
Journal of Psychiatry & Neuroscience : JPN
|
April 3, 2019
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study
Deanna L. Kelly, Haley K. Demyanovich, Katrina M. Rodriguez, et al.
Schizophrenia Research
|
March 1, 2025
Building a two-state learning healthcare system for persons with first episode psychosis
Jill A Marsteller, Richard W Goldberg, Yasmine Boumaiz, et al.
Biological Psychiatry
|
December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia
Robert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Research
|
March 3, 2015
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
L Fredrik Jarskog, Martin T Lowy, Richard A Grove, et al.
Page
of 60